Stay updated on Niraparib-bev-Dostarlimab vs Niraparib-bev vs Std of Care Clinical Trial
Sign up to get notified when there's something new on the Niraparib-bev-Dostarlimab vs Niraparib-bev vs Std of Care Clinical Trial page.

Latest updates to the Niraparib-bev-Dostarlimab vs Niraparib-bev vs Std of Care Clinical Trial page
- Check4 days agoChange DetectedThe page has been updated to include new information about the ENGOT-OV42 / NSGO-AVATAR study, specifically mentioning the drugs Carboplatin and Paclitaxel, while significant details about the study's design and inclusion criteria have been removed.SummaryDifference40%
- Check11 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check18 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check26 days agoNo Change Detected
- Check54 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check69 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
- Check76 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
Stay in the know with updates to Niraparib-bev-Dostarlimab vs Niraparib-bev vs Std of Care Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Niraparib-bev-Dostarlimab vs Niraparib-bev vs Std of Care Clinical Trial page.